These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23714730)
1. Predicting outcome by images? De Ruysscher D Clin Cancer Res; 2013 Jul; 19(13):3334-6. PubMed ID: 23714730 [TBL] [Abstract][Full Text] [Related]
2. Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images. Zhang C; Liao C; Penney BC; Appelbaum DE; Simon CA; Pu Y Radiology; 2015 Jun; 275(3):862-9. PubMed ID: 25584710 [TBL] [Abstract][Full Text] [Related]
3. Lung-cancer staging with PET-CT. Sharieff W N Engl J Med; 2009 Oct; 361(16):1607; author reply 1608. PubMed ID: 19842248 [No Abstract] [Full Text] [Related]
7. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer. Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611 [TBL] [Abstract][Full Text] [Related]
8. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients. Kim SJ; Chang S Oncol Res Treat; 2015; 38(11):577-85. PubMed ID: 26599271 [TBL] [Abstract][Full Text] [Related]
9. Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer. Lin S; Han B; Yu L; Shan D; Wang R; Ning X Nucl Med Commun; 2011 Jun; 32(6):479-85. PubMed ID: 21394047 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT. Jiménez-Bonilla JF; Quirce R; Martínez-Rodríguez I; Banzo I; Rubio-Vassallo AS; Del Castillo-Matos R; Ortega-Nava F; Martínez-Amador N; Ibáñez-Bravo S; Carril JM Lung Cancer; 2013 Jul; 81(1):71-6. PubMed ID: 23597930 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy. Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. Mac Manus MP; Hicks RJ; Matthews JP; McKenzie A; Rischin D; Salminen EK; Ball DL J Clin Oncol; 2003 Apr; 21(7):1285-92. PubMed ID: 12663716 [TBL] [Abstract][Full Text] [Related]
13. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. Lee KS; Jeong YJ; Han J; Kim BT; Kim H; Kwon OJ Radiographics; 2004; 24(6):1617-36; discussion 1632-6. PubMed ID: 15537972 [TBL] [Abstract][Full Text] [Related]
14. The evolving role of thoracoscopic lobectomy for non-small cell lung cancer. Reed CE J S C Med Assoc; 2011 Aug; 107(4):143-5. PubMed ID: 22057746 [No Abstract] [Full Text] [Related]
15. Correlation of serum proteomics patterns of sCD200 (OX-2), sApo-2L (sTRAIL), vitamin-D and homocysteine to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer. Bisgnin A; Yalcin AD; Gumuslu S; Kargi B; Kargi A; Savas B; Strauss LG J BUON; 2013; 18(4):1099-100. PubMed ID: 24344047 [No Abstract] [Full Text] [Related]
16. Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer. Ohri N; Piperdi B; Garg MK; Bodner WR; Gucalp R; Perez-Soler R; Keller SM; Guha C Lung Cancer; 2015 Jan; 87(1):23-7. PubMed ID: 25468149 [TBL] [Abstract][Full Text] [Related]
17. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
19. PET-CT in preoperative staging of lung cancer. Fischer BM; Lassen U; Højgaard L N Engl J Med; 2011 Mar; 364(10):980-1. PubMed ID: 21388332 [No Abstract] [Full Text] [Related]
20. [Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool]. Pneumologie; 2008 Apr; 62(4):188. PubMed ID: 18393179 [No Abstract] [Full Text] [Related] [Next] [New Search]